Eligibility for anti-fibrotic therapy of patients in British Thoracic Society (BTS) UK IPF Registry varies according to the reference values used to calculate FVC

P. Molyneaux (London, United Kingdom), M. Loughenbury (London, United Kingdom), S. Welham (London, United Kingdom), J. Hutchinson (Notingham, United Kingdom), H. Adamali (Bristol, United Kingdom), A. Fahim (Wolverhampton, United Kingdom), S. Agnew (Liverpool, United Kingdom), W. Funston (Gateshead, United Kingdom), S. Haney (Ashington, United Kingdom), L. Ho (Oxford, United Kingdom), J. Richardson (London, United Kingdom), H. Almond (Bury St Edmunds, United Kingdom), S. Jones (Bury St Edmunds, United Kingdom), L. Nicol (Edinburgh, United Kingdom), K. Spinks (Lymington, United Kingdom), A. Wilson (Norwich, United Kingdom), L. Spencer (Liverpool, United Kingdom)

Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Session: What is hot in idiopathic pulmonary fibrosis?
Session type: E-poster session
Number: 1798
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Molyneaux (London, United Kingdom), M. Loughenbury (London, United Kingdom), S. Welham (London, United Kingdom), J. Hutchinson (Notingham, United Kingdom), H. Adamali (Bristol, United Kingdom), A. Fahim (Wolverhampton, United Kingdom), S. Agnew (Liverpool, United Kingdom), W. Funston (Gateshead, United Kingdom), S. Haney (Ashington, United Kingdom), L. Ho (Oxford, United Kingdom), J. Richardson (London, United Kingdom), H. Almond (Bury St Edmunds, United Kingdom), S. Jones (Bury St Edmunds, United Kingdom), L. Nicol (Edinburgh, United Kingdom), K. Spinks (Lymington, United Kingdom), A. Wilson (Norwich, United Kingdom), L. Spencer (Liverpool, United Kingdom). Eligibility for anti-fibrotic therapy of patients in British Thoracic Society (BTS) UK IPF Registry varies according to the reference values used to calculate FVC. 1798

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy and safety of applying the British Thoracic Society (BTS) criteria to determine appropriateness of follow up in general respiratory clinics
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012

Does adherence to the British Thoracic Society (BTS) asthma guidelines prevent readmission within the first month
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007



Appropriateness of ATS/ERS recommended lung volume reference values for contemporary Australasian children
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011


COPD classification according GOLD 2013 and Latin American Thoracic Association (ALAT) recommendations in PUMA study
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016

Forced expiratory manoeuvres in children: do they meet ATS and ERS criteria for spirometry?
Source: Eur Respir J 2001; 18: 655-660
Year: 2001



Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline - ERS pocket guideline
Source: Guideline 2017
Year: 2017

Are we conforming to American Thoracic Society guidelines on the quality of spirometry?
Source: Eur Respir J 2003; 22: Suppl. 45, 513s
Year: 2003

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Source: Eur Respir J 2015; 46: 903-975
Year: 2015



Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
Source: Eur Respir Rev, 29 (157) 200287; 10.1183/16000617.0287-2020
Year: 2020



International European Respiratory Society/American Thoracic Society guidelines on severe asthma
Source: Eur Respir J 2014; 44: 1377-1378
Year: 2014


International European Respiratory Society/American Thoracic Society guidelines on severe asthma
Source: Eur Respir J 2014; 44: 1378-1379
Year: 2014


Stratification of COPD in primary health care: use of Spanish Society of Pulmonology (SEPAR) and Spanish Society of Community Health Medicine (SEMFYC) guidelines
Source: Eur Respir J 2005; 26: Suppl. 49, 544s
Year: 2005

Quality of care in bronchiectasis using the European Respiratory Society Guidelines as a reference standard- data from the EMBARC registry
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021



Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Source: Eur Respir J , 49 (3) 1600791; DOI: 10.1183/13993003.00791-2016
Year: 2017



Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Source: Guideline 2017
Year: 2017


The use of British Thoracic Society (BTS) guidelines for chronic obstructive pulmonary disease in general practice
Source: Eur Respir J 2001; 18: Suppl. 33, 347s
Year: 2001

Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Source: Eur Respir J, 50 (3) 1602265; 10.1183/13993003.02265-2016
Year: 2017



Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Source: Guideline 2017
Year: 2017

Oxygen prescription and oxygen therapy on the wards according to British Thoracic Society Guidelines: Experience of an acute trust in the UK
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
Source: Eur Respir Rev 2015; 24: 159-172
Year: 2015